More Evidence of Clock Gene Dysfunction from Virus. Implications for Chronic Fatigue Syndrome and Other Diseases!

 


It has been reported from past studies that the clock gene is disrupted in chronic fatigue syndrome but how this occurs is unknown. The clock gene regulates circadian rhythms mammals and controls proteins that regular regulate daily cycles, like sleep/wake cycles and feeding. It has been proposed that secondary messengers also control circadian rhythms. In mammals, a group of neurons that form a structure called the suprachiasmatic nucleus (SCN) is known as the master clock. This is in the hypothalamus and controls biological clock functions in peripheral tissue. In a new study, scientists looked at how cAmp and calcium can influence circadian rhythms, which was previously unclear. As the author writes, "cAMP is a molecule that is important for many cellular functions." These scientists found that by blocking a neural network, the cAMP function was lost. By doing the same thing to calcium ions, the rhythms not lost and therefore, it was demonstrated that calcium is regulated by intracellular mechanisms. Next, they focused on the extracellular peptide called vasoactive intestinal peptide (VIP), which has been known to modulate cAMP. The experiment demonstrated that when VIP was blocked the rhythm of cAMP was also blocked. They also showed that VIP is regulated by a circadian rhythm and this regulation was controlled by a neural network. Lastly, the scientists determined that manipulation of cAmp with external stimuli already known to alter cAmp functioning, it changed the circadian rhythm of the clock gene and changed behavior. These results “suggest that intracellular cAMP affects both molecular and behavioral circadian rhythms involving the clock gene. It was concluded," intracellular cAMP rhythms in the SCN are regulated by a VIP -dependent neural network." (1)

In past reports, many people have claimed that CFS developed after a virus, and it has been proposed that subsequent dysbiosis may influence its symptoms. Well, a recent study shows that it in mice after infection VIP decreased in a cytokine-dependent manner. (If this is true, what happens when there is a chronic cytokine response?) In addition, a supplemental VIP administration alleviated some of the deficits in the resulting mitochondrial function and ATP caused by inflammatory mediators. According to the author, “improvements in mitochondrial function and epithelial protection was due to VIP associated reduction in oxidative stress.  However, treatment with VIP did not alter infection outcome.

It is now known that VIP- controlled biological function in the intestine may influence physiological homeostasis which it is believed to be altered in CFS. What happens when there is a deficiency of VIP in the gut? Well, it has now been demonstrated to reduce a healthy diversity of the microbiome and illustrates that VIP has an important role in controlling the composition of the gut microbiota. One study showed the changes included a depletion in “good bacteria” and an increase in “bad bacteria” in the microbiome that resembled one associated with inflammatory disorders like IBD.  In addition, there was a reduction in butyrate-producing firmicutes. (3) Recently, a study showed a butyrate deficiency in CFS. Maybe, just maybe, the loss of communication between VIP neural circadian control is further disrupted after alterations of CFS microbiome. It is apparent that VIP is an anti-inflammatory mediator but also has been noted that VIP can be inflammatory as well. This may be due to VIP is present in so many different tissues “including epithelial, the nerves, and the endocrine and immune systems. VIP contributes to important physiological functions including anion secretion, regulation of permeability of epithelial type junctions, mucosal inflammation, glycemic control, Th1 and Th2 balance and tumor growth. Currently, VIP has been suggested as a therapeutic target for conditions such as diarrhea, IBD, diabetes, autoimmune diseases, neurodegenerative disorders, lung disease and cancer. It is also used to treat mold toxicity and the resulting chronic inflammatory immune response syndrome (CIRS). VIP treatment may also be used to treat autoimmune rheumatoid arthritis.” (4)


Search for more on this blog! #CFS   #dysbiosis   #CLOCK Gene




1)     1) Clockwork Biology: cAMP Molecules illuminate Circadian Rhythm mysteries. Nagoya University Sctechdaily.com September 1, 2023.

2)     2) Maiti AK, Sharba S, Navabi N, Lindén SK. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection. PLoS One. 2018 Sep 25;13(9):e0204567. doi: 10.1371/journal.pone.0204567. PMID: 30252907; PMCID: PMC6155558.

3)    3) Bains M, Laney C, Wolfe AE, Orr M, Waschek JA, Ericsson AC, Dorsam GP. Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice. Front Microbiol. 2019 Dec 2;10:2689. doi: 10.3389/fmicb.2019.02689. PMID: 31849864; PMCID: PMC6900961.

4)   4) Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Res. 2019 Sep 12;8:F1000 Faculty Rev-1629. doi: 10.12688/f1000research.18039.1. PMID: 31559013; PMCID: PMC6743256.

Comments